Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

In the latest trading session, Gilead Sciences (GILD) closed at $104.90, marking a -0.74% move from the previous day.

近日，跨国生物制药巨头吉利德科学（Gilead Sciences）在全球范围内宣布了一系列裁员措施，其中包括将于2025年中终止细胞治疗子公司Kite Pharma在费城的工厂运营。与此相关，吉利德中国的裁员消息也引发了广泛关注。这一消息的背后，究竟隐藏了什么样的市场动态和行业变革？

据《界面新闻》报道，吉利德中国的这一裁员消息虽然在业内引发关注，但公司高层坚定地指出这是为了更好地应对即将上市的关键产品，包括年给药两次的HIV预防药物来那帕韦（lenacapavir）。这一新药的推出，不仅意味着吉利德在HIV领域或将迎来新的增长点，也标志着公司对市场变化的敏感把握与积极应对。

Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...

The Trump administration's cuts to HIV prevention will lead to new infections, medical costs and death, experts warn.

We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a ...

HIV-HBV coinfection rates can reach 25% in ... Originally published by Gilead Sciences. View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

With that said, let's consider two top dividend stocks that should navigate the current storm relatively well and continue ...